Blood Flow Mismatch in Pancreatic Cancers Greenville NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

Gary Richard Jones, MD
(503) 494-1543
3282 Charles Blvd
Greenville, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Or Hlth Sci Univ Sch Of Med, Portland Or 97201
Graduation Year: 1980

Data Provided by:
Lillian P Burke, MD
(252) 744-2560
3E 127 Brody Med Sci Bldg
Greenville, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Spencer O Raa, MR
(919) 551-2554
3E-106 Brody Bldg
Greenville, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Radhika Shah, MD
(252) 744-2560
Hem Onc Brody 3E 127 600 Moye Blvd
Greenville, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Charles W Daeschner
(252) 744-2335
600 Moye Blvd
Greenville, NC
Specialty
Pediatric Hematology-Oncology

Data Provided by:
Howard David Homesley, MD
(252) 744-3587
Leo Jenkins Cancer Ctr
Greenville, NC
Specialties
Oncology (Cancer), Gynecological Oncology
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1967

Data Provided by:
Susan Gustke, MD
(252) 744-1000
202 W Berkshire Rd
Greenville, NC
Specialties
Internal Medicine, Hematology-Oncology
Gender
Female
Education
Medical School: Wv Univ Sch Of Med, Morgantown Wv 26506
Graduation Year: 1964
Hospital
Hospital: Pitt County Memorial Hospital, Greenville, Nc
Group Practice: Ecu Physicians Brody School Of Medicine

Data Provided by:
Ulf Lennart Karlsson, MD
(800) 782-8581
Greenville, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Karolinska Inst, Med Fak, Stockholm, Sweden
Graduation Year: 1968

Data Provided by:
James Ronald W Humbert, MD
(252) 816-4676
288 W Teaching Annex
Greenville, NC
Specialties
Oncology (Cancer), Pediatrics
Gender
Male
Education
Medical School: Centre Med Univ, Fac De Med, Geneve, Switzerland (Univ De Geneve)
Graduation Year: 1964

Data Provided by:
Darla K Liles
(252) 744-2383
600 Moye Blvd
Greenville, NC
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com